$-0.10 EPS Expected for Critical Outcome Technologies Inc. (COTQF); Last Week Xenia Hotels & Resorts, Inc. (XHR) Analysts

December 8, 2017 - By Linda Rogers

Analysts expect Critical Outcome Technologies Inc. (OTCMKTS:COTQF) to report $-0.10 EPS on December, 18.They anticipate $0.00 EPS change or 0.00% from last quarter’s $-0.1 EPS. The stock decreased 4.46% or $0.0357 during the last trading session, reaching $0.7643. About shares traded. Critical Outcome Technologies Inc. (OTCMKTS:COTQF) has 0.00% since December 8, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 7 analysts covering Xenia Hotels & Resorts (NYSE:XHR), 4 have Buy rating, 0 Sell and 3 Hold. Therefore 57% are positive. Xenia Hotels & Resorts has $23.0 highest and $17 lowest target. $21.17’s average target is -1.17% below currents $21.42 stock price. Xenia Hotels & Resorts had 13 analyst reports since September 1, 2015 according to SRatingsIntel. The company was initiated on Friday, October 27 by FBR Capital. Instinet initiated it with “Buy” rating and $22 target in Wednesday, December 14 report. The rating was initiated by Raymond James with “Market Perform” on Tuesday, July 26. Morgan Stanley downgraded the stock to “Equal-Weight” rating in Thursday, March 17 report. Wells Fargo initiated the stock with “Outperform” rating in Monday, May 2 report. Wells Fargo downgraded the stock to “Market Perform” rating in Tuesday, December 13 report. As per Wednesday, November 18, the company rating was initiated by JMP Securities. The stock of Xenia Hotels & Resorts, Inc. (NYSE:XHR) has “Hold” rating given on Tuesday, September 1 by Zacks. Morgan Stanley upgraded Xenia Hotels & Resorts, Inc. (NYSE:XHR) rating on Tuesday, October 13. Morgan Stanley has “Overweight” rating and $22 target. Wells Fargo maintained the stock with “Outperform” rating in Friday, October 6 report. See Xenia Hotels & Resorts, Inc. (NYSE:XHR) latest ratings:

09/11/2017 Broker: FBR Capital Rating: Hold New Target: $23.0
27/10/2017 Broker: FBR Capital Rating: Hold New Target: $23.0 Initiate
06/10/2017 Broker: Wells Fargo Rating: Outperform Old Target: $19.5 New Target: $20 Maintain
16/06/2017 Broker: Morgan Stanley Rating: Equal Weight Old Target: $17.00 New Target: $19.00 Target Up

Xenia Hotels & Resorts, Inc. operates as a self-advised and self-administered real estate investment trust that invests primarily in full service, lifestyle, and urban upscale hotels in the United States. The company has market cap of $2.29 billion. As of October 4, 2017, it owned 39 hotels comprising 11,533 rooms across 18 states and the District of Columbia. It has a 16.7 P/E ratio. The firm has elected to be taxed as a REIT and would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders.

The stock decreased 0.37% or $0.08 during the last trading session, reaching $21.42. About 358,799 shares traded. Xenia Hotels & Resorts, Inc. (NYSE:XHR) has risen 19.57% since December 8, 2016 and is uptrending. It has outperformed by 2.87% the S&P500.

Critical Outcome Technologies Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company has market cap of $13.19 million. The Company’s lead compound is COTI-2, a novel small molecule activator of misfolded mutant p53 proteins, which is in Phase I clinical trial for the treatment of gynecologic cancers, as well as head and neck squamous cell carcinoma. It currently has negative earnings. The firm also develops COTI-219, a novel oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS function; drug candidates for the treatment of acute myelogenous leukemia, SOX9, MRSA, multiple sclerosis, and AlzheimerÂ’s disease; and HIV integrase inhibitors.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: